Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug 4:8:11.
doi: 10.1186/s13044-015-0024-4. eCollection 2015.

Circulating thyrotropin receptor messenger ribonucleic acid is not an effective marker in the follow-up of differentiated thyroid carcinoma

Surasawadee Ausavarat  1 , Jiraporn Sriprapaporn  1 , Busara Satayaban  1 , Wanna Thongnoppakhun  2 , Aunchalee Laipiriyakun  1 , Boontham Amornkitticharoen  1 , Rujaporn Chanachai  1 , Chaveevan Pattanachak  1
Affiliations

Circulating thyrotropin receptor messenger ribonucleic acid is not an effective marker in the follow-up of differentiated thyroid carcinoma

Surasawadee Ausavarat et al. Thyroid Res. .

Abstract

Background: Circulating thyrotropin receptor messenger ribonucleic acid (TSHR mRNA) assay has been validated in the follow-up of differentiated thyroid carcinoma (DTC) because of its high sensitivity during thyroid hormone therapy and no interference with endogenous anti-thyroglobulin antibodies (TgAb) compared to serum thyroglobulin (Tg). We investigated the efficacy of TSHR mRNA assay in 160 DTC patients using quantitative PCR (qPCR).

Findings: Only TSHR mRNA level of structural persistent disease with TgAb-positive (3.47 (2.97-9.53) pg equivalents/μg total RNA; p = 0.013) and its subgroup of distant metastasis patients with TgAb-positive (5.55 (3.28-12.52) pg equivalents/μg total RNA; p = 0.009) were significantly different from patients with no evidence of disease (2.32 (1.44-3.94) pg equivalents/μg total RNA). Applying cutoff at 2.00 pg equivalents/μg total RNA enabled us to predict structural persistent disease patients with a sensitivity of 62.3 % and a specificity of 42.9 %. Although, the sensitivity of TSHR mRNA assay in TgAb-postive patients (88.2 %) was superior than serum Tg (47.1 %) (p = 0.00002), the accuracy of the test is only 54.5 %.

Conclusions: This study demonstrated that TSHR mRNA assay has good sensitivity in TgAb-positive patients but it is neither specific enough as a first-line of testing nor a surrogate marker in the follow-up of our DTC patients.

Keywords: DTC; TSHR mRNA; Thyroid mRNA; qPCR.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
TSHR mRNA level of each study group during thyroid hormone therapy. Data is represented as interquartile range with median of each group in boxplot. Circles and asterisks are outlier and extreme data, respectively. The cutoff for assay positivity is at 2.00 pg equivalents/μg total RNA
See this image and copyright information in PMC

References

    1. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167–214. doi: 10.1089/thy.2009.0110. - DOI - PubMed
    1. Spencer CA. Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC) J Clin Endocrinol Metab. 2011;96:3615–27. doi: 10.1210/jc.2011-1740. - DOI - PubMed
    1. Ditkoff BA, Marvin MR, Yemul S, Shi YJ, Chabot J, Feind C, et al. Detection of circulating thyroid cells in peripheral blood. Surgery. 1996;120:959–64. doi: 10.1016/S0039-6060(96)80041-9. - DOI - PubMed
    1. Verburg FA, Lips CJ, Lentjes EG, de Klerk JM. Detection of circulating Tg-mRNA in the follow-up of papillary and follicular thyroid cancer: how useful is it? Br J Cancer. 2004;91:200–4. - PMC - PubMed
    1. Bellantone R, Lombardi CP, Bossola M, Ferrante A, Princi P, Boscherini M, et al. Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic type: results of a prospective study. Cancer. 2001;92:2273–9. doi: 10.1002/1097-0142(20011101)92:9<2273::AID-CNCR1573>3.0.CO;2-Y. - DOI - PubMed

LinkOut - more resources